MP Assay
Ongoing Challanges
Mycoplasma pneumoniae infection often presents with non-specific symptoms, mimicking viral infections, which can lead to underdiagnosis or misdiagnosis.
Culture methods are slow (taking weeks) and are rarely used clinically. PCR is sensitive but not universally available in low-resource settings. Serology (IgM/IgG) has delayed positivity and cross-reactivity issues.
High transmission rate via respiratory droplets in crowded settings (e.g., schools, military barracks).
Most severe in children aged 5–15 years, often causing school outbreaks.
Product Overview
The EasyNAT MP Assay is an automated, in vitro nucleic acid amplification test for the qualitative detection of “Mycoplasma pneumonia”(MP) DNA in oropharyngeal swab samples from individuals with suspected MP infection.
Fast results in 25 minutes
Designed to provide an accurate LOD: 1000 copies/mL
Random access with independent module testing, available anytime, anywhere
Clinical Value
Assists in the clinical diagnosis of suspected pneumonia, distinguishing it from viral pneumonia, bacterial pneumonia, and tuberculosis.
Sensitive PCR testing contributes to early identification, preventing serious complications.
Reduces turn-around time, avoids secondary visits, and improves the patient experience.
Highly automated; does not require a three-zone PCR lab; suitable for testing at all levels of healthcare institutions.
